Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Contact

Gabby Arias, media@aiusa.org 

Press Release

Pfizer Reports Massive Revenues While Hurting the Chances of Millions to Get Vaccinated Against COVID-19

WASHINGTON -

Responding to news that Pfizer reported $14 billion in third-quarter revenue for vaccines and is set to earn $36 billion from vaccine sales by the end of the year on the back of the Covid-19 vaccine roll-out, Patrick Wilcken, Amnesty International’s Head of Business and Human Rights, said:

“That Pfizer has been able to earn billions of dollars in revenue in the last three months alone, while failing to provide vaccines to billions of people, is a failure of catastrophic proportions. Not only has the vast majority of its vaccines gone to high and upper-middle-income countries but Pfizer has also consistently refused to waive its intellectual property rights and share vaccine technology, while at the same time benefitting from billions of dollars in government funding and advance orders from wealthy countries.

“The apparently unquenchable thirst for profits of big pharmaceutical companies, like Pfizer, is fueling an unprecedented human rights crisis. If left unchecked, the rights of billions of people around the world to life and to health will continue to be in jeopardy.

“Amnesty International is supporting the World Health Organization’s target of vaccinating 40% of those in low and lower-middle-income countries by the end of 2021 with our 100 Day Countdown campaign. We only have 59 days until the end of the year. That’s 59 days for states to urgently redistribute hundreds of millions of surplus doses that they’re sitting on, and for vaccine developers to ensure that at least half the doses they produce go to these countries.

“It’s not too late for Pfizer and its big pharma competitors to do what’s right for humanity and fulfill their human rights obligations. At the end of the month, WTO members will meet in Geneva to discuss the TRIPS Waiver to temporarily lift intellectual property rights, which could expand the world’s manufacturing capacity of Covid-19 vaccines. Big pharma must stop lobbying against the waiver so that world production can be boosted and diversified, and every person on the planet can get a shot at these life-saving vaccines.”

###

Amnesty International is a worldwide movement of people who campaign for internationally recognized human rights for all. Our supporters are outraged by human rights abuses but inspired by hope for a better world - so we work to improve human rights through campaigning and international solidarity. We have more than 2.2 million members and subscribers in more than 150 countries and regions and we coordinate this support to act for justice on a wide range of issues.

'No More Hiding': Sanders Says Make GOP Vote on Popular Policies

"The American people have a right to know where their senators stand on the most important issues impacting their lives."

Jake Johnson ·


Sanders Demands End to Medicare Premium Hike From Alzheimer's Drug

Biogen's original price for the controversial drug, he argues, "is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry."

Jessica Corbett ·


'Monumental Victory' as Biden Cancels Boundary Waters Mining Leases

Rep. Betty McCollum called the administration's decision "a rejection of the deeply flawed and politically motivated process under the Trump administration."

Brett Wilkins ·


Rights Groups Demand Hearings on the 'Fourth Amendment Is Not For Sale Act'

"The longer Congress waits," warned one advocate, "the stronger and more dangerous this industry will become."

Kenny Stancil ·


Democrats Urge Biden to Abandon Dangerous Trump Policies on Nuclear Weapons

With the Nuclear Posture Review, say congressional lawmakers, the president can ensure "future generations can finally be free from the nuclear sword of Damocles that hangs over all our heads."

Andrea Germanos ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo